Trial NCT05829434

View at ClinicalTrials.gov 
Org. Study IDs: MAGROLIC
Secondary IDs: EU Trial Number

Last trial update was posted on 2024-02-12

MeSH Interventions

Cytarabine Magrolimab

MeSH Conditions

Myelodysplastic Syndromes Preleukemia

Other Conditions

Acute Myeloid Leukemia Myelodysplastic Neoplasm

Stopping Reasons

Trial was stopped prematurely due to safety reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID